logo

KMTS

Kestra Medical·NASDAQ
--
--(--)
--
--(--)
4.84 / 10
Netural

Fund flow data reveal a generally positive trend, with inflows dominant in block, medium, large, and extra-large categories (overall inflow ratio 0.516). However, small-cap flows are negative, indicating fragmented demand. Analyst coverage is limited to three reports, with two Buys and one Neutral; historical win rates for these analysts are modest (33-50%), and the market-weighted rating (1.81) lags the current price rise, suggesting limited conviction.

FundamentalSentiment(4.84)Technical
Fund Flow Rating
Analyst RatingBuy

Wall Street Opinions

Buy

Strong Buy

0%

Buy

67%

Hold

0%

Sell

0%

Strong Sell

0%

Date2025-12-15
InstitutionGoldman Sachs
Times predicted3
Historical Win Rate33.3%
What is the analyst consensus for KMTS?
  • KMTS holds a Bearish analyst rating, with 67% of experts assigning a Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 4.84/10 (Netural).